Immunovia AB (publ) (STO:IMMNOV)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.4450
-0.0120 (-2.63%)
Jul 14, 2025, 2:55 PM CET

Immunovia AB Revenue

Immunovia AB had revenue of 139.00K SEK in the quarter ending March 31, 2025, a decrease of -10.90%. This brings the company's revenue in the last twelve months to 914.00K, down -24.53% year-over-year. In the year 2024, Immunovia AB had annual revenue of 931.00K, down -40.89%.

Revenue (ttm)
914.00K
Revenue Growth
-24.53%
P/S Ratio
153.04
Revenue / Employee
101.56K
Employees
9
Market Cap
139.88M

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 931.00K -644.00K -40.89%
Dec 31, 2023 1.58M 430.00K 37.55%
Dec 31, 2022 1.15M 301.00K 35.66%
Dec 31, 2021 844.00K 482.00K 133.15%
Dec 31, 2020 362.00K 6.00K 1.69%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Swedish Orphan Biovitrum AB 26.24B
Sectra AB 3.31B
Getinge AB 35.57B
Asker Healthcare Group AB 15.57B
Camurus AB 2.04B
Medicover AB 23.56B
AddLife AB 10.42B
Vimian Group AB 4.24B
Revenue Rankings